Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Anel

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Immunobiology|March 6, 2007
Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutationManuel J Del-Rey, Javier Manzanares, Alberto Bosque, et al.
Pharmaceutics|February 27, 2026
The Combination of Immunomodulatory Secretome and Liposome-Bound TRAIL Improves Knee Osteoarthritis Symptoms in an Ovine ModelJoaquín Marco-Brualla, Felícito García-Álvarez, Sara Fuente, et al.
Plos Pathogens|December 21, 2020
Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preferenceElena Mata, Damien Farrell, Ruoyao Ma, et al.
Blood|April 22, 2006
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndromeManuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, et al.
Nanotechnology|March 23, 2016
TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cellsDiego De Miguel, Ana Gallego-Lleyda, José María Ayuso, et al.
Cancers|August 26, 2022
PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial DeficienciesRuth Soler-Agesta, Joaquín Marco-Brualla, Martha Minjárez-Sáenz, et al.
Molecular Oncology|September 13, 2023
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X<sub>L</sub> in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patientsManuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, et al.
Oncoimmunology|May 8, 2015
Human NK cells activated by EBV<sup>+</sup> lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cellsDiego Sánchez-Martínez, Gemma Azaceta, Aura Muntasell, et al.
Journal of Leukocyte Biology|February 25, 2005
Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytesJosé M Martín-Fernández, Juan A Cabanillas, Miguel Rivero-Carmena, et al.
Cancer Letters|October 12, 2016
High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancerDiego De Miguel, Ana Gallego-Lleyda, José María Ayuso, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Immunobiology|March 6, 2007
Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutationManuel J Del-Rey, Javier Manzanares, Alberto Bosque, et al.
Pharmaceutics|February 27, 2026
The Combination of Immunomodulatory Secretome and Liposome-Bound TRAIL Improves Knee Osteoarthritis Symptoms in an Ovine ModelJoaquín Marco-Brualla, Felícito García-Álvarez, Sara Fuente, et al.
Plos Pathogens|December 21, 2020
Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preferenceElena Mata, Damien Farrell, Ruoyao Ma, et al.
Blood|April 22, 2006
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndromeManuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, et al.
Nanotechnology|March 23, 2016
TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cellsDiego De Miguel, Ana Gallego-Lleyda, José María Ayuso, et al.
Cancers|August 26, 2022
PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial DeficienciesRuth Soler-Agesta, Joaquín Marco-Brualla, Martha Minjárez-Sáenz, et al.
Molecular Oncology|September 13, 2023
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X<sub>L</sub> in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patientsManuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, et al.
Oncoimmunology|May 8, 2015
Human NK cells activated by EBV<sup>+</sup> lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cellsDiego Sánchez-Martínez, Gemma Azaceta, Aura Muntasell, et al.
Journal of Leukocyte Biology|February 25, 2005
Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytesJosé M Martín-Fernández, Juan A Cabanillas, Miguel Rivero-Carmena, et al.
Cancer Letters|October 12, 2016
High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancerDiego De Miguel, Ana Gallego-Lleyda, José María Ayuso, et al.
Pageof 10